Key facts
- It has raised $200K; the latest was Early Stage VC in Jun 2025.
- Notable investors include The Engine, Activate Global, HopStone Capital, Johns Hopkins Technology Ventures, Wolf Point Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Drūl
- ·The full record, as it builds
Funding rounds
No funding rounds for Drūl are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Drūl
Manufacturer of an oral microbiome analysis device designed for detecting oral and chronic diseases through saliva testing. The company's device collects saliva, isolates harmful bacteria, and quantifies bacterial concentration to identify gum disease, tooth decay, and biomarkers for conditions like oral cancers and diabetes, enabling individuals to monitor their oral health and receive early disease detection.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2021
- Employees
- 2
- Website
- justdrul.com/
- Ownership
- Privately Held (backing)
Drūl doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Drūl shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Drūl in its N-PORT filings yet. We sweep new filings monthly.